vention. However, heart failure had several characteristics that made it the clear choice. It is the final common pathway in the natural history of most cardiovascular disorders. Coronary, valve, myocardial, and congenital cardiac diseases all often ultimately lead to heart failure. The prevalence of diastolic abnormalities in our increasingly obese, diabetic, hypertensive, and elderly society has also increased the prevalence of cardiac failure, which is now the most rapidly increasing category of cardiac patients. Heart failure is a condition that is truly encountered and managed by virtually all cardiovascular specialists.
Interestingly, the field of heart failure has been majorly impacted and expanded by advances in electrophysiology, and vice versa. Heart failure frequently leads to cardiac arrhythmias, and as these patients survive longer, the incidence of rhythm disorders is increasing proportionately. It is the common experience that most patients with heart failure ultimately exhibit some abnormality of rhythm or conduction, and that the largest category of patients with electrophysiological disturbances are those with heart failure. Moreover, the development of new therapies for heart rhythm disorders, such as cardiac resynchronization and implantable defibrillators, has markedly increased the armamentarium for the treatment of heart failure. Accordingly, the knowledge base required for the optimal management of these patients has expanded. In fact, in classifying manuscripts under topic headings for the cover of each JACC issue, I have encountered so many papers that deal with electrophysiological disturbances in heart failure patients that we strongly considered creating a single journal devoted to both disorders.
The field of heart failure has also been impacted by the emergence of left ventricular assist devices (LVADs) both as bridge and destination therapy. Patients who had undergone cardiac transplantation always presented a challenge to the general cardiologist. Now it is becoming progressively more commonplace to have patients in the hospital in whom LVADs have been placed. Until recently I always felt very comfortable in covering the heart failure service when necessary. Now I feel intimidated and inadequate if LVAD patients are included. It is not surprising, therefore, that the American Board of Internal Medicine has established a Certificate of Added Qualifications for Advanced Heart Failure and Cardiac Transplantation.
All of the foregoing issues give strong support to the rationale of creating a new publication devoted to the management of heart failure. However, just as Steve Jobs had the goal to create a constellation of products that worked together to serve the multiple wishes of his customers, we at JACC seek to have an integrated line of publications to serve the same purpose. This clearly has been a major driver in developing the new journal. Jobs created a system at Apple that could fulfill the music, telephone, and digital consumption needs of customers through the integrated group of iPOD, iPHONE, iPAD, and iTunes products. Similarly, our vision is to ultimately provide our readers with a co-ordinated group of publications that cover the spectrum of cardiovascular diseases. JACC: Heart Failure is just the latest in that JACC family line of journals.
While it is difficult to say that Steve Jobs was the inspiration for JACC: Heart Failure, his philosophy and implementation was certainly analogous in many respects to our own vision. Having been the first cardiology journal to create daughter publications devoted to specific cardiovascular disciplines, it was almost mandatory that we not rest but rather continue to evolve. JACC: Heart Failure will further round out the integrated JACC family of journals, and we are convinced that our readers will embrace this new publication as avidly as they did our Imaging and Interventions offspring. Heart failure is clearly one of the most ubiquitous and rapidly expanding conditions in cardiovascular medicine. With the expertise and enthusiasm of Chris O'Connor leading the effort, we anticipate that July 1, 2012, will bring a wealth of submissions and that January/February 2013 will provide a spectacular inaugural issue. Our belief is that the rationale for JACC: Heart Failure shares much in common with the philosophy of Steve Jobs and Apple. Our only hope, and anticipation, is that we be nearly as successful.
